Submitted by carl-charlesworth on Tue, 23/10/2018 - 15:46
There are currently a supply issues with Epilim Chronosphere (sodium valproate) 250mg Modified Release Granules and Epanutin (phenytoin) oral suspension.
Submitted by Nicola-Swanborough on Tue, 02/10/2018 - 16:10
An independent safety review into the epilepsy medication, sodium valproate, is now officially open and has put out a 'call for evidence' from those affected by the drug.
Submitted by Nicola-Swanborough on Wed, 15/08/2018 - 16:50
A GP practice in London could be closed down after inspectors found that staff had failed to warn women of the risks around the epilepsy medication sodium valproate during pregnancy.
Submitted by paige-dawkins on Mon, 30/04/2018 - 15:54
Our CEO Clare Pelham, a member of the Sodium Valproate Expert Working Group, commented on the news of the new regulations surrounding sodium valproate.
Submitted by Nicola-Swanborough on Tue, 24/04/2018 - 11:44
Epilepsy Society today welcomes new regulatory measures to stop babies being born with avoidable disabilities after being exposed to the drug, sodium valproate, in the womb.But the charity cautions that unless the regulations are backed by a public communications campaign, the long-fought-for measures may not reach those women and girls who have no option but to take the drug.
Information about and concerns around the anti-epileptic drug sodium valproate.
Submitted by Nicola-Swanborough on Fri, 23/03/2018 - 14:10
Epilepsy Society's chief executive Clare Pelham has called today's announcement of new regulatory measures around sodium valproate, 'a landmark moment for all women who have ever been prescribed the epilepsy drug.'
Submitted by paige-dawkins on Tue, 27/02/2018 - 15:59
Emma Friedmann is a parent carer of her 19 year old son who has fetal valproate syndrome. In February 2018, she attended parliament when the government announced their decision to review handling of concerns around sodium valproate.
Submitted by Nicola-Swanborough on Wed, 21/02/2018 - 18:30
Epilepsy Society's chief executive Clare Pelham has praised the Government's decision to announce a forward-looking review that will address the way the healthcare system has handled the concerns of patients in its care and make certain that lessons are learned and history does not repeat itself.
Submitted by Nicola-Swanborough on Mon, 12/02/2018 - 17:03
New measures to avoid the exposure of unborn babies to the epilepsy drug, sodium valproate have been announced by the safety committee of the European Medicines Agency (EMA).